Kidney Function Tests Market Trends, Growing Demand and Business Opportunities by 2028

Kidney Function Tests Industry Overview

The global kidney function tests market size was valued at USD 777.06 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028.

Factors, such as investments by market players, increasing R&D activities, high prevalence of kidney diseases, and rising government initiatives, are expected to significantly drive market growth. Kidney function tests are simple laboratory tests used for investigating and evaluating functions of the kidney. Increased risk of Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI) due to the rising prevalence of diabetes and hypertension has drastically upsurged the demand for these products. The outbreak of coronavirus has further fueled the product demand.

According to the study published by the National Kidney Foundation, people hospitalized due to Covid-19 are at significant risk of developing AKI. The study stated that Covid-19 patients were twice as likely to develop AKI as compared to non-Covid-19 patients. Health authorities recommended that Covid-19 patients who had an AKI should be tested regularly as their risk of developing CKD is higher than others. These factors will propel the kidney function tests market growth over the forecast period.

Gather more insights about the market drivers, restrains and growth of the Global Kidney Function Tests Market

Rising R&D initiatives for the development of novel products are expected to significantly boost market growth during the forecast period. For instance, in January 2020, Germany-based SphingoTec GmbH launched its IB10 sphingotest penKid, a Point-of-Care (PoC) test for Proenkephalin (penKid). This biomarker enables real-time evaluation of kidney function with a normal blood test. In addition, growing investments in the field of kidney function testing are further expected to fuel the market growth. In January 2020, Sweden-based Elypta AB raised a seed round worth USD 7.0 million to develop the first urine test for kidney cancer.

Chronic kidney disease has become a global public health problem having a high economic cost associated with it. According to the National Institutes of Health (NIH), the global prevalence of CKD is around 14.0%. Also, the prevalence of CKD risk factors, such as diabetes, hypertension, and obesity, is on the rise owing to lifestyle changes. This has led to an increased demand for mandatory screening tests in patients with hypertension and diabetes for CKD, thus creating a high product demand. As per the data published by the International Diabetes Federation, in 2019, around 463.0 million adults had diabetes globally, which is predicted to reach 700 million by 2045.

Furthermore, several public-private organizations are undertaking initiatives to facilitate kidney disease testing in key regions. For instance, in July 2020, the National Kidney Foundation (NKF) in collaboration with the National Committee for Quality Assurance (NCQA), introduced a new kidney health evaluation measure, specifically for patients with diabetes. The new guidelines suggest routinely test of diabetes patients for kidney diseases. Such initiatives are anticipated to create a lucrative environment for market growth.

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

• Molecular Diagnostics Market: The global molecular diagnostics market size was valued at USD 37.04 billion in 2021 and is expected to decline at a compound annual growth rate (CAGR) of -1.6% from 2022 to 2030. The shrinking of the market can be attributed to the decline in demand for molecular COVID-19 testing during the forecast period.

• In Vitro Diagnostics Market: The global in vitro diagnostic market size was valued at USD 111.67 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 0.2% from 2022 to 2030. The growth can be attributed to the increasing adoption of IVDowing to the rise in testing due to the pandemic.

Kidney Function Tests Market Segmentation

Grand View Research has segmented the global kidney function tests market on the basis of product, end-use, and region:

Kidney Function Tests Product Outlook (Revenue, USD Million, 2016 - 2028)

• Clearance Tests

• Urine Tests

• Blood Tests

• Dilution and Concentration Tests

• Other Tests

Kidney Function Tests End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals

• Diagnostic Laboratories

• Research Laboratories and Institutes

• Others

Kidney Function Tests Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America

• Europe

• Latin America

• Asia Pacific

• MEA

Key Companies profiled:

Some prominent players in the Global Kidney Function Tests Market include

• Abbott Laboratories

• Danaher Corporation (Beckman Coulter, Inc.)

• F. Hoffmann-La Roche

• Sysmex Corporation

• Siemens Healthineers

• Randox Laboratories

• Quest Diagnostics

• Acon Laboratories

• Nova Biomedical

• Laboratory Corporation of America Holdings (LabCorp)

Order a free sample PDF of the Kidney Function Tests Market Intelligence Study, published by Grand View Research.